Imperial College London

DrJoSzram

Faculty of MedicineNational Heart & Lung Institute

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 7351 8349joanna.szram Website

 
 
//

Location

 

G46Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Szram:2020:10.1016/j.mpmed.2020.03.001,
author = {Szram, J},
doi = {10.1016/j.mpmed.2020.03.001},
journal = {Medicine (United Kingdom)},
pages = {412--416},
title = {Occupational airways disease},
url = {http://dx.doi.org/10.1016/j.mpmed.2020.03.001},
volume = {48},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Airway diseases can be either caused or made worse by workplace exposures; early recognition of occupational disease is crucial to achieving a successful outcome for the patient. Population research estimates that 10–15% of adult asthma presentations (either new cases or exacerbations of existing disease) can be attributed to a work exposure. Work-exacerbated and occupational asthma have different causal pathways and therefore require different approaches by healthcare professionals in partnership with patients, and their employers. Obtaining a comprehensive, precise job history and carefully applying simple but powerful diagnostic investigations are key to successfully distinguishing between the two conditions. Appropriate management can result in cure, although in most cases there is a significant socioeconomic cost to the patient. Toxic exposures to workplace respiratory irritants can also result in airways disease; symptoms are generally short lived and self-limiting but can occasionally result in an asthma-like syndrome as well as inducible laryngeal obstruction or other upper airway disorders. Several specific occupational exposures have been causally associated with chronic obstructive pulmonary disease; diagnosis is complicated by the long latency between exposure and clinically evident disease, and frequent confounding by smoking. Other rare, occupationally induced airway diseases such as obliterative bronchiolitis require specialist consideration.
AU - Szram,J
DO - 10.1016/j.mpmed.2020.03.001
EP - 416
PY - 2020///
SN - 1357-3039
SP - 412
TI - Occupational airways disease
T2 - Medicine (United Kingdom)
UR - http://dx.doi.org/10.1016/j.mpmed.2020.03.001
VL - 48
ER -